Status:
COMPLETED
Evaluation of Cognitive State Using Neurosteer EEG System
Lead Sponsor:
Neurosteer Ltd.
Conditions:
Cognitive Decline
Eligibility:
All Genders
45+ years
Brief Summary
This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through EEG record...
Detailed Description
One of the major problems in the prevention and treatment of neurological disorders, is the lack of cost effective and reliable tools to assess neurodegeneration on a large scale at a very early stage...
Eligibility Criteria
Inclusion
- Men and women over the age of 45.
- MMSE score \< 30.
- MMSE score ≥ 10.
- Patient is able to collaborate.
- No other cognitive comorbidity.
- No seizure event.
Exclusion
- Advanced stage of cognitive decline (MMSE \< 10).
- Any verbal or non-verbal form of objection from patient or form patient's family member or significant other.
- Presence of several cognitive comorbidity.
- Damage to integrity of scalp and/or skull.
- Skin irritation in the facial and forehead area.
- Significant hearing impairments.
- History of drug abuse.
Key Trial Info
Start Date :
September 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 9 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04386902
Start Date
September 19 2019
End Date
July 9 2020
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dorot - Netanya Geriatric Medical Center
Netanya, Israel, 42420